IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $3,000 | -25.0% | 203 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $3,000 | +50.0% | 203 | +22.3% | 0.00% | 0.0% |
Q4 2016 | $2,000 | -66.7% | 166 | -33.3% | 0.00% | -66.7% |
Q3 2016 | $6,000 | 0.0% | 249 | +20.9% | 0.00% | 0.0% |
Q2 2016 | $6,000 | +20.0% | 206 | +19.8% | 0.00% | 0.0% |
Q1 2016 | $5,000 | -28.6% | 172 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $7,000 | +16.7% | 172 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $6,000 | -25.0% | 172 | 0.0% | 0.00% | -20.0% |
Q2 2015 | $8,000 | 0.0% | 172 | -3.9% | 0.01% | 0.0% |
Q1 2015 | $8,000 | +60.0% | 179 | +4.1% | 0.01% | +66.7% |
Q4 2014 | $5,000 | 0.0% | 172 | -15.3% | 0.00% | -25.0% |
Q3 2014 | $5,000 | 0.0% | 203 | +11.5% | 0.00% | +33.3% |
Q2 2014 | $5,000 | 0.0% | 182 | 0.0% | 0.00% | -25.0% |
Q1 2014 | $5,000 | – | 182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |